Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
MAIA Biotechnology, Inc. (MAIA) had Normalized Income after Taxes of $-6.37M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.37M |
|
-- |
|
-- |
|
$6.95M |
|
$-6.95M |
|
$0.58M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
|
Normalized Income after Taxes |
$-6.37M |
$-6.95M |
|
$-6.95M |
|
45.21M |
|
45.21M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$35.32M |
|
-- |
|
$0.01M |
|
$35.32M |
|
$6.32M |
|
-- |
|
$1.24M |
|
$7.56M |
|
$27.76M |
|
$27.76M |
|
$27.76M |
|
60.67M |
|
| Cash Flow Statement Financials | |
$-5.31M |
|
-- |
|
$31.05M |
|
$8.66M |
|
$34.41M |
|
$25.76M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.94% |
|
-22.94% |
|
-18.03% |
|
-22.94% |
|
$0.46 |
|
$-0.12 |
|
$-0.12 |
|